Aurisco Pharmaceutical Co.,Ltd.

SSE:605116.SS

21.07 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Operating Activities:
Net Income 0095.203106.40882.18456.873136.6550.01945.87824.50169.65675.88640.85335.19850.53950.40432.57317.02237.14253.05550.00866.25647.838
Depreciation & Amortization 00022.21122.21120.978-38.18219.84619.84617.74117.74117.65817.65815.89915.89912.20312.20332.024-16.3116.31027.90
Deferred Income Tax 000000-10.153-5.420211.218-35.45980.91600000000000
Stock Based Compensation 00010.71508.154-17.69217.69206.349-2.0392.03900000000000
Change In Working Capital 000-96.1750-136.42252.789-52.7890-210.80789.413-89.4130-76.7130.895-30.8950-16.3652.409-2.4090-66.2540
Accounts Receivables 000-65.5110-98.179-0.7280.7280-84.83349.443-49.443011.2942.474-2.4740-20.7238.104-8.1040-21.1960
Change In Inventory 000-43.6340-72.51953.518-53.5180-125.97439.969-39.9690-89.00530.729-30.72901.828-3.2343.2340-11.4640
Change In Accounts Payables 00000020.785-20.7850-17.9843.997-3.99700000000000
Other Working Capital 00012.97034.276-20.78520.785017.984-3.9973.99701.002-2.3082.30802.53-2.462.460-33.5940
Other Non Cash Items 0039.732-5.1767.7246.77917.91238.365-19.846-24.501-69.656-11.2-15.47421.977-50.539-50.404-32.573-17.022-37.142-53.055-50.008-66.256-47.838
Operating Cash Flow 00134.93579.0289.90482.674141.32467.71445.87824.50169.65675.88625.37941.05771.7365.24923.53510.0473.204113.05518.18250.4310
Investing Activities:
Investments In Property Plant And Equipment -108.222-102.057-184.455-113.206-140.559-111.43-85.693-66.621-41.732-93.08-31.554-40.513-51.079-128.108-46.93-29.209-46.367-62.681-44.089-33.146-18.884-15.935-20.103
Acquisitions Net 0000.1240.06362.4740.1880.0820.0710.2480.0720.2250.081-1.98447.2690.1550.08762.88444.1004.75819.819
Purchases Of Investments -224.28-139.778585.335-758.1350-121.438-0.1880.413-0.413-11.441-30-500-26.137-30-20-35-40200-32-13020
Sales Maturities Of Investments 269.135-107.609-647.564757.1350.477-59.03558.238-0.495-0.07120.04130.07649.775056.35620.16720052.47-2000200.821-49.789
Other Investing Activites 0.172215.528-213.9691200.54-121.1321.321.320.07100-49.6380.0812.016-46.9320.4470.087-62.681-44.08921.0870.02-15.935-19.346
Investing Cash Flow -63.196-133.916-460.6535.918-140.019-231.762-26.135-65.302-42.074-84.231-31.407-90.151-50.998-95.873-56.425-28.762-81.28-50.008-44.079-12.059-50.86443.71-49.419
Financing Activities:
Debt Repayment 21.17596.148656.06948.1834.97527.92832.1253.7425.67530.277-0.3252.7053.460000000000
Common Stock Issued 000000000000001.132-1.1320000000
Common Stock Repurchased 00000-1.200000000000000000
Dividends Paid -1.279-6.23-3.421-89.363-0.247-64.991-0.344-65.737-0.539-52.337-2.072-50.203000-48.120000-3600
Other Financing Activities -16.921-91.85292.5052.406-2.40618.467-1.01929.484-0.3831.407-0.103-50.2030-3.23420-1.132-26.838309.78000.760
Financing Cash Flow 2.976-1.934745.153-41.17432.32346.01530.762-32.5114.75331.622-2.5-47.4973.46-5.2342-48.12-1.132-26.838309.780-360.760
Other Information:
Effect Of Forex Changes On Cash 2.69315.9853.551-10.0374.52-1.526-1.0277.5111.154-3.5653.8863.608-0.427-1.7820.286-1.075-1.255-4.714-2.273-0.3311.025-8.4181.784
Net Change In Cash -31.821-88.945422.986-86.655-13.749-90.564144.925-22.58843.69221.64-13.694-87.151-22.586-61.83117.591-12.708-60.133-71.519336.633100.665-67.65686.482-7.144
Cash At End Of Period 736.603768.03856.975446.915400.662414.011504.575359.65382.238338.546316.906330.6417.751440.337502.168484.576497.285557.417628.937292.304191.638259.295172.813